Treatment with the SIRT2 inhibitor AGK2 and genetic inhibition of AK-1 or SIRT2 also alleviates α-syn-mediated DA neuronal loss both in vitro and in a Drosophila PD model [104]. Here, SIRT2 is linked to Parkinson disease.